Medpace Holdings Inc

• Country

  United States of America

• Sector

  Health Care

• Industry group

  Pharmaceuticals, Biotechnology & Life Sciences

• Industry

  Life Sciences Tools & Services

• Sub-sector

  Health Care

• Capitalization (millions of $)

  12238.3

• Ticker

  MEDP.O

• ISIN

  US58506Q1094

• IPO date

  2016-08-11

• Availability on Russian exchanges

  Yes

• Reporting for

  2024-02-13

• Date fact. publication of reports

  2023-12-31

Medpace Holdings, Inc. is a provider of clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.